MPS Pharmaa Limited Approves Workforce Retrenchment for Business Diversification into Natural Healthcare
MPS Pharmaa Limited Approves Workforce Retrenchment for Business Diversification into Natural Healthcare is drawing significant interest across the industry.
MPS Pharmaa Limited's Board approved retrenchment of 10 factory workers effective April 02, 2026, at its Haryana manufacturing facility as part of strategic business diversification into Ayurvedic, Unani and Homeopathic medicines manufacturing. The permanent retrenchment, conducted in compliance with The Industrial Relations Code, 2020, aims to optimize costs while transitioning to operations requiring specialized workforce for natural healthcare products. The company previously intimated this diversification plan to stock exchanges in September 2025.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Abhishek Sharma doubtful for India vs Pakistan T20 World Cup encounter, reveals Suryakumar Yadav
- Netflix's Slow Horses Replacement Is A 9-Part Crime Thriller Series That Keeps Getting Better
- Boston brings fitness to new heights with winter workout series
- Who is Billy Walkowiak? An advocate for consumer safety attends the State of the Union
Source: Original →